Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NTRB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
0 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 14
16 filers reported a long position in NTRB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $558K | 174.9K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $199.4K | 62.5K | -10.8% |
| VANGUARD FIDUCIARY TRUST CO | $80.1K | 25.1K | Unchanged |
| STATE STREET CORP | $79.6K | 25K | Unchanged |
| CITADEL ADVISORS LLC | $60.6K | 19K | New |
| NORTHERN TRUST CORP | $36.9K | 11.6K | -17% |
| Haven Private, LLC | $36.3K | 11.4K | Unchanged |
| BlackRock, Inc. | $34K | 10.7K | +11.7% |
| OSAIC HOLDINGS, INC. | $11.8K | 3.7K | -24.1% |
| Vanguard Global Advisers, LLC | $8.6K | 2.7K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.